Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma

Clinical trial NCT00091104 · COMPLETED

Trial details

NCT number

NCT00091104

Sponsor

National Institutes of Health Clinical Center (CC)

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2004-07-01

Primary completion

2010-08-01

Enrollment

136

View on ClinicalTrials.gov